Schmid, C. N., Sponagel, K., Bacher, U., Seipel, K., Porret, N., Wiedemann, G., . . . Pabst, T. (2025). Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma. International Journal of Molecular Sciences, 26(16), 8021. https://doi.org/10.3390/ijms26168021
Chicago Style (17th ed.) CitationSchmid, Corinne Natalie, Katharina Sponagel, Ulrike Bacher, Katja Seipel, Naomi Porret, Gertrud Wiedemann, Michèle Hoffmann, Michael Daskalakis, and Thomas Pabst. "Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma." International Journal of Molecular Sciences 26, no. 16 (2025): 8021. https://doi.org/10.3390/ijms26168021.
MLA (9th ed.) CitationSchmid, Corinne Natalie, et al. "Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma." International Journal of Molecular Sciences, vol. 26, no. 16, 2025, p. 8021, https://doi.org/10.3390/ijms26168021.